Ikarian Capital, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$633,000
-31.7%
511,186
+7.5%
0.08%
-39.9%
Q4 2021$927,000
-43.7%
475,693
-20.8%
0.14%
+19.0%
Q3 2021$1,647,000
-43.0%
600,693
-34.5%
0.12%
-50.2%
Q2 2021$2,887,000
-53.0%
916,552
-68.2%
0.23%
+12.6%
Q1 2021$6,147,000
-29.4%
2,885,952
-35.7%
0.21%
-46.1%
Q4 2020$8,703,0004,485,9520.38%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders